This study reveals the immunomodulatory mechanism of ADQ in inhibiting breast cancer metastasis and highlights the TAM/CXCL1/Treg axis as a promising therapeutic target for breast cancer immunotherapy. The gene discussed is CXCL1; the disease is breast carcinoma.